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Peeling skin disease (PSD) is an autosomal recessive skin disorder caused by 
mutations in CDSN and is characterized by superficial peeling of the upper epidermis. 
Corneodesmosin (CDSN) is a major component of corneodesmosomes that plays an 
important role in maintaining epidermis integrity. Herein, we report a patient with PSD 
caused by a novel homozygous large deletion in the 6p21.3 region encompassing the 
CDSN gene, which abrogates CDSN expression. Several genes including C6orf15, 
PSORS1C1, PSORS1C2, CCHCR1, and TCF19 were also deleted, however, the patient 
showed only clinical features typical of PSD. The deletion size was 59.1 kb. Analysis of 
the sequence surrounding the breakpoint showed that both of the telomeric and 
centromeric breakpoints existed within Alu-S sequences that were oriented in opposite 
directions. These results suggest an Alu-mediated recombination event as the mechanism 
underlying the deletion in our patient. 
 
 





Peeling skin disease (PSD), a generalized inflammatory form of peeling skin 
syndrome, is an autosomal recessive skin disorder caused by mutations in CDSN and is 
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characterized by superficial peeling of the upper epidermis (1, 2). Patients with PDS have 
been reported to carry nonsense or frameshift mutations resulting in complete loss of 
expression of corneodesmosin (CDSN), a major component of corneodesmosomes that 
plays an important role in maintaining epidermis integrity. Herein, we report a patient 
with PDS caused by a novel homozygous large deletion in the 6p21.3 region 
encompassing CDSN.  
 
 
Material and methods 
 
Patient report 
A 3-week-old Japanese girl from non-consanguineous parents was hospitalized 
for severe skin anomalies, hypereosinophilia (6,075/µL), and hypoproteinemia (Fig. 1A-
C). Serum IgE levels were slightly elevated at 51 IU/L, and allergen-specific IgE were all 
negative. Thereafter the patient developed IgE-mediated fish allergy. She is now 16 years 
of age and has suffered from frequent episodes of widespread patchy peeling and 
erythema (Fig. 1D). Serum IgE levels were significantly elevated (14,940 IU/L) with high 
allergen-specific IgE against multiple inhalant and food allergens with age: class 5 for 
house dust mite; class 4 for kiwi fruit; class 3 for caw’s milk, egg white, shrimp, oyster, 
codfish and flounder; and class 2 for crab. 
 
Mutation, array comparative genomic hybridization (CGH) and breakpoint analysis 
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DNA was extracted from blood samples using a standard method. The CDSN 
gene was amplified from genomic DNA using specific primers (2). Array CGH and 





The lack of expression of CDSN protein in her skin biopsy (Fig. 1E, F) and 
amplification of any CDSN sequences from her DNA prompted us to perform array 
comparative genomic hybridization (CGH) analysis (Fig. 2A). We were able to clearly 
demonstrate a region of continuously reduced copy number around 6p21.3, in which 
CDSN was located. There were no significant copy number alterations in other parts of 
the patient’s genome. Direct sequencing analysis of the breakpoint PCR products 
demonstrated that the breakpoints were chr6:31,069,672 and chr6:31,128,857. The 
deletion size was 59.1 kb. The centromeric breakpoint was located within intron 2 of 
TCF19. More importantly, Alu sequences were found to be involved in the deletion (Fig. 





Repetitive Alu sequences are widely distributed and important for insertional 
mutagenesis and recombination events in a variety of human genetic disorders (4). 
 5 
Unequal homologous recombination may occur between two Alu sequences oriented in 
the same direction, resulting in duplications, deletions and translocations. In fact, around 
0.3% of all human genomic diseases have been reported to likely result from Alu-
mediated unequal homologous recombination. However, in our patient, the two Alu 
sequences responsible for the deletion were oriented in opposite directions (Fig. 2B, C). 
Although Alu sequences inserted in the opposite directions have been found to be more 
prone to illegitimate recombination when they are less than 20 bp apart from each other 
(5), there have been rare reports of observations similar to ours. In addition, studies of 
comparative analysis of the chimpanzee and human genomes have demonstrated the 
uncommonness of this type of Alu-mediated deletion (6). Analysis of the junction 
sequence allowed us to postulate that non-homologous end joining (NHEJ) is the most 
likely mechanism responsible for the deletion. Further investigations are necessary to 
assess how Alu sequences oriented opposite directions would contribute to 
recombination-mediated damage to the human genome. 
Mutations in the CDSN gene in humans have been originally identified in patients 
with autosomal dominant hypotrichosis simplex of the scalp (HSS) (7). To date, all 
mutations responsible for HSS have been reported to be heterozygous nonsense mutations, 
namely p.Gln200X, p.Gln209X, p.Gln215X and p.Tyr239X, all of which lead to 
truncated CDSN proteins. Aggregates formed by the dominant negative effect of mutated 
CDSN may be toxic to the hair follicle cells resulting in HSS (7-10). In contrast, genetic 
defects in patients with PDS have been shown to be homozygous nonsense (p.Lys59X) or 
frameshift mutations leading to complete loss of CDSN expression (2, 11-13). Consistent 
with these findings, our patient carrying the homozygous deletion mutation exhibited no 
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protein expression of CDSN, and the parents and brother, who were heterozygous carrier 
(Fig. 2D), did not show any abnormalities in the hair and skin. No products were 
amplified by the breakpoint PCR from 130 alleles of ethnically-matched healthy controls. 
However, because of the non-consanguinity in the parents, genotyping studies using 
larger number of samples will be required to assess whether the deletion allele could have 
a significant frequency in the Japanese population. 
In addition to CDSN, there were several other genes involved in the deletion in 
our patient: C6orf15, PSORS1C1, PSORS1C2, CCHCR1, and TCF19. Most of them have 
been reported to be associated with increased risk of psoriasis. However, the precise roles 
of these genes in psoriasis susceptibility, as well as their physiological roles, remain to be 
determined. It is also known that genetic variations of CCHCR1 are likely related to 
cervical epithelial cell transformation and nevirapine-induced rash in addition to psoriasis, 
none of which has been observed in our patient. On the other hand, no human disease has 
been reported to be associated with defective expression of these genes. Accordingly, our 
patient showed clinical features typical of PDS but no unexplained symptoms that could 
be related to other deleted genes. 
Absence of CDSN protein leads to defects in the epidermal barrier, resulting in 
predisposition towards atopic dermatitis. Netherton syndrome is a rare dermatosis caused 
by mutations in SPINK5, encoding LEKTI, which is involved in the degradation of 
CDSN. Therefore, PDS, Netherton syndrome and atopic dermatitis may show clinical 
overlap between each other, especially in childhood. In fact, our patient was initially 
diagnosed with Netherton syndrome-like condition. Interestingly, marked eosinophilia 
was demonstrated at the onset in the patient, which probably resulted from the presence 
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of intense systemic allergic inflammation, i.e., severe atopic dermatitis. Serum IgE levels 
and allergen-specific IgE against multiple allergens increased dramatically with age. 
These results further suggest the importance of maintaining skin barrier function in the 
environment to prevent the subsequent development of allergic diseases after birth. 
In summary, our studies identified the novel homozygous large deletion encompassing 
CDSN as an additional type of mutation in PDS, and demonstrated its genomic 
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Fig. 1. Characterization of the skin lesions. 
(A) Superficial peeling and ichthyosiform erythroderma at 1 month of age. (B, C) 
Hematoxylin and eosin staining of the skin biopsy specimen, original magnification x40 
and x100. Extensive detachment of the stratum corneum, hyperkeratosis, parakeratosis, 
and eosinophilic infiltration were shown in the epidermis. (D) Extensive peeling of the 
skin and erythema over the forearms at 16 years of age. (E, F) Immunohistochemistry. 
The skin biopsy specimens were stained with anti-corneodesmosin antibody (Atlas 
antibodies, Stockholm, Sweden). A specimen from a normal control showed positive 
staining in the granular layers (E), whereas corneodesmosin was not detectable in the 
patient’s specimen (F). Bars indicate 100 µm for B and 50 µm for C, E and F. 
 
Fig. 2. Characterization of the deletion mutation and the breakpoint. 
(A) Analysis of the array comparative genomic hybridization. The red band indicates the 
region of continuously reduced copy number in the 6p21.3 region. (B) Schematic 
representation of the deletion and the Alu sequences involved in the recombination. The 
telomeric breakpoint was intergenic between MUC22 and C6orf15 loci, and the 
centromeric breakpoint was located within intron of TCF19. Both breakpoints existed 
within Alu sequences, which were oriented in opposite directions. Arrows indicate Alu 
sequences. Boxes represent exons of the TCF19 gene, and shaded areas represent the 
coding regions. Numbering according to NC_000006.11. (C) Sequences surrounding the 
junction alongside the reference sequences of Alu-Sc and Alu-Sg. All sequences are 
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shown in 5’ to 3’ direction. Microhomologies are underlined. (D) Carrier status of the 
family members. PCR amplification for CDSN and the breakpoint were shown. 
Amplified products were obtained from both PCR reactions for each DNA sample from 
the patient’s father, mother and younger brother, indicating that they were heterozygous 
carriers. No amplified products were obtained from control DNA due to the absence of 
the deletion. Marker lanes contain 100-bp (top) and 1-kb (bottom) molecular size markers. 
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